Commission Delegated Regulation (EU) 2017/751 of 16 March 2017 amending Delegated Regulations (EU) 2015/2205, (EU) 2016/592 and (EU) 2016/1178 as regards the deadline for compliance with clearing obligations for certain counterparties dealing with OTC derivatives (Text with EEA relevance. )
Text
Article-level text, parsed from the formex manifestation.
Article 1 Amendment to Delegated Regulation (EU) 2015/2205
In Article 3(1) of Delegated Regulation (EU) 2015/2205, point (c) is replaced by the following: ‘(c) 21 June 2019 for counterparties in Category 3;’.
Article 2 Amendment to Delegated Regulation (EU) 2016/592
In Article 3(1) of Delegated Regulation (EU) 2016/592, point (c) is replaced by the following: ‘(c) 21 June 2019 for counterparties in Category 3;’.
Article 3 Amendment to Delegated Regulation (EU) 2016/1178
In Article 3(1) of Delegated Regulation (EU) 2016/1178, point (c) is replaced by the following: ‘(c) 21 June 2019 for counterparties in Category 3;’.
Article 4 Entry into force
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Relations
What this act cites, and what cites it.
Show relationsVersions
Point-in-time consolidated versions of this act.
Show versions